BioSpace News Archive

Shares of General Electric jumped as much as 13 percent in trading this morning after Danaher Corporation announced it was acquiring the conglomerate’s biopharma business, GE Biopharma, for $21.4 billion.

University Health Network’s Joint Department of Medical Imaging of Toronto, Canada, has purchased 10 CARESTREAM DRX-Evolution Plus digital radiography systems and eight CARESTREAM DRX-Revolution Mobile X-ray Systems.

Estrogen in the brain is important to keep neurons communicating and memories being made, scientists report.

Jeffrey D. Marrazzo, chief executive officer of Spark Therapeutics, said his company is the only biotech company that has successfully commercialized a gene therapy for a genetic disease in the United States.

There are numerous questions that often come up in job interviews that most people hate. Examples include “What’s your greatest weakness?” and “Where do you see yourself in five years?”

Lonza announced the internal alignment of its business structure to accelerate growth along the Healthcare Continuum® and strengthen the Microbial Control business.

Medigene AG reported that the European Patent Office intends to grant a European Patent for the patent application EP3303591A1 covering a T cell receptor building block library that is suitable for rapid reconstruction and testing of newly discovered TCR sequences against classical antigens as well as neoantigens.

Medtronic plc, the global leader in medical technology, announced a successful conclusion to the 12th International Conference on Advanced Technologies & Treatments for Diabetes, which took place in Berlin from February 20 - 23, 2019.

LexaGene Analyzer is 97.5% Concordant with Reference Laboratory Generated Data and will take just one hour versus 2 – 5 days to return results

Ultragenyx Pharmaceutical Inc. announced that it has commenced an underwritten public offering of up to $250,000,000 of shares of its common stock.